Back to Blog

Formus Hip in Commercial Use

Formus Labs receives usage revenue as more than 90 surgeries have been planned on Formus Hip since the roll-out of the software in January. 

Seven surgeons across New Zealand and Australia are currently using the automated 3D pre-operative planning software, with more being trained in the product each month. 

“We are very excited about this new phase and we are working closely with Zimmer Biomet to ensure the success of our new users," says Formus Labs CEO Dr Ju Zhang.

Orthopedic surgeons typically perform 10 to 20 surgeries per month. With more than 1500 surgeons across New Zealand and Australia, it’s easy to see the growth opportunities of our platform. 

“As the word continues to get out there about the Formus Platform, we want to build trust and success in a core community of early adopters to help us grow our user-base exponentially,” says Zhang.

More from the Lab

Formus Labs Hip Platform Receives FDA Clearance!

Formus Labs today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Formus Hip as the first “automated radiological image processing software” for hip replacement pre-op planning.

Read Story

Internationally Renowned Orthopaedic Surgeon Thought Leaders Join Formus Labs’ Clinical Advisory and Development Board.

Formus Labs, creator of the world's first automated 3D, AI-enabled pre-operative planner for joint replacement surgeries, today announces the expansion of its clinical advisory board. Three global thought leaders in the field of arthroplasty, Dr. J. Bohannon Mason, Dr. Atul Kamath and Dr. James A. Germano will help shape the next generation of Formus Labs’ innovative planning technology and will support the company’s expansion into new markets.

Read Story

Formus Labs, a Pioneering Developer of Orthopedic Surgery Planning Technology, Hires Ex-Johnson & Johnson Executive, Polly Teevan, To Lead Global Commercial Strategy

Formus Labs, creator of the world's first fully-automated 3D planner for joint replacement surgeries, today announced it has hired Polly Teevan as Chief Marketing Officer. Teevan will oversee global commercial and marketing strategy, and lead Formus to expand its presence in the US and international markets leveraging her deep customer relationships, industry knowledge and commercial experience.

Read Story

Subscribe for the latest news and product updates

We will never share your email address with third parties.